3.5.2. Pancreatic Cancer in Genetically Engineered Mouse Model (GEMM): Gene Therapy of GEMM (LSL-KrasG12D/+; LSL-Trp53R172H/+; Pdx-1-Cre (KPC)) mice with Ad-p14ARFmin-MDR1n-p14-tBID. This evidence concerns the gene PDX1 and familial pancreatic carcinoma.